Evidence map›Paper›PMID 26205304›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2015

Impact of Personal Characteristics and Technical Factors on Quantification of Sodium 18F-Fluoride Uptake in Human Arteries: Prospective Evaluation of Healthy Subjects.

Björn Alexander Blomberg, Anders Thomassen, Pim A de Jong, Jane A Simonsen, Marnix G E H Lam, Anne L Nielsen, Hans Mickley, Willem P T M Mali, Abass Alavi, Poul F Høilund-Carlsen

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03233243 (Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT), which is not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03233243 phase4completedstarted 2020, after this paper: background citation

Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT

Ran2020Enrolled40Registered outcomes3Posted comparisons0ConditionsAtherosclerosis, Cardiovascular Diseases, Molecular ImagingArmsRosuvastatin Oral Tablet
Open the trial in the graph
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. European journal of nuclear medicine and molecular imaging · 2020
    Trial
  3. Trial
  4. Review
  5. Observational
  6. Article
  7. Common carotid segmentation inClinical physiology and functional imaging · 2023
    Article
  8. Review
  9. Review
  10. Longitudinal analysis of atherosclerotic plaques evolution: anJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  11. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  12. Determinants ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  13. Article
  14. Temporal relationship betweenJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Advances in Quantitative Analysis ofMolecular imaging · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Björn Alexander BlombergDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands b.a.blomberg@umcutrecht.nl.
Anders ThomassenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Pim A de JongDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Jane A SimonsenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Marnix G E H LamDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Anne L NielsenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Hans MickleyDepartment of Cardiology, Odense University Hospital, Odense, Denmark.
Willem P T M MaliDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Abass AlaviDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; and.
Poul F Høilund-CarlsenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Odense University Hospital · DKUniversity Medical Center Utrecht · NLHospital of the University of Pennsylvania · USUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledSodium 18F-fluoride (18F-NaF) PET/CT imaging is a promising imaging technique for the assessment of atherosclerosis but is hampered by a lack of validated quantification protocols. Both personal characteristics and technical factors can affect quantification of arterial 18F-NaF uptake. This study investigated whether blood activity, renal function, injected dose, circulating time, and PET/CT system affect quantification of arterial 18F-NaF uptake.

methodsEighty-nine healthy subjects were prospectively examined by 18F-NaF PET/CT imaging. Arterial 18F-NaF uptake was quantified at the level of the ascending aorta, aortic arch, descending thoracic aorta, and coronary arteries by calculating the maximum 18F-NaF activity (NaFmax), the maximum/mean target-to-background ratio (TBRmax/mean), and the maximum blood-subtracted 18F-NaF activity (bsNaFmax). Multivariable linear regression assessed the effect of personal characteristics and technical factors on quantification of arterial 18F-NaF uptake.

resultsNaFmax and TBRmax/mean were dependent on blood activity (β=0.34 to 0.44, P<0.001, and β=-0.68 to -0.58, P<0.001, respectively) and PET/CT system (β=-0.80 to -0.53, P<0.001, and β=-0.80 to -0.23, P<0.031, respectively). bsNaFmax depended on PET/CT system (β=-0.91 to -0.57, P<0.001) but not blood activity. This finding was observed at the level of the ascending aorta, aortic arch, descending thoracic aorta, and the coronary arteries. In addition to blood activity and PET/CT system, injected dose affected quantification of arterial 18F-NaF uptake, whereas renal function and circulating time did not.

conclusionThe prospective evaluation of 89 healthy subjects demonstrated that quantification of arterial 18F-NaF uptake is affected by blood activity, injected dose, and PET/CT system. Therefore, blood activity, injected dose, and PET/CT system should be considered to generate accurate estimates of arterial 18F-NaF uptake.

Indexed as

RadiopharmaceuticalsAdultAgedAgingAortaArteriesFemaleFluorine RadioisotopesHealthy VolunteersHumansImage Processing, Computer-AssistedMaleMiddle AgedObserver VariationProspective StudiesRadionuclide ImagingFluorine RadioisotopesRadiopharmaceuticalsSodium FluorideatherosclerosisPET/CTquantificationsodium 18F-fluoride (18F-NaF)vascular calcification

Identifiers

PMID26205304
OpenAlexW2180119803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.